Vimarsana
Biggest News Aggregation in the World

Peter Goadsby News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Goadsby. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Goadsby Today - Breaking & Trending Today

'Life-changing' once-a-day migraine pill which halves the number of crippling attacks gets green light for NHS use - Vimarsana News

'Life-changing' once-a-day migraine pill which halves the number of crippling attacks gets green light for NHS use

The pill - sold under the brand name Aquipta and made by pharmaceutical company AbbVie - could be a blessing for some 170,000 sufferers in England.

Life-changing Once-daily Migraine Pill That Halves The Number Of Crippling Attacks Gets The Green Light For Use On The NHS - Vimarsana News

Life-changing Once-daily Migraine Pill That Halves The Number Of Crippling Attacks Gets The Green Light For Use On The NHS

The pill - sold under the brand name Aquipta and made by pharmaceutical company AbbVie - could be a blessing for some 170,000 sufferers in England.

AbbVie's AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults - Vimarsana News

AbbVie's AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults

 The National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance (FDG) recommending AQUIPTA® (atogepant), the oral, once-daily calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) as an option in suitable patients for preventing migraine i...

'Exploding head syndrome'? Inside a mysterious, disturbing sleep condition - Vimarsana News

'Exploding head syndrome'? Inside a mysterious, disturbing sleep condition

This little understood disorder leads some to hear loud crashes or booms as they're drifting off to sleep.

CGRP in Migraine Prodrome Can Stop Headache, Reduce Severity - Vimarsana News

CGRP in Migraine Prodrome Can Stop Headache, Reduce Severity

For the first time, new research shows that taking a specific class of migraine medication during the prodromal phase reduces the development and severity of the subsequent headache.